BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15973992)

  • 1. [Expression of prostate stem cell antigen (PSCA) and selection of its specific binding peptide].
    Hou LH; Du Y; Zhang XP; An XP; Chen W
    Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):694-8. PubMed ID: 15973992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.
    Dannull J; Diener PA; Prikler L; Fürstenberger G; Cerny T; Schmid U; Ackermann DK; Groettrup M
    Cancer Res; 2000 Oct; 60(19):5522-8. PubMed ID: 11034097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells.
    Morgenroth A; Cartellieri M; Schmitz M; Günes S; Weigle B; Bachmann M; Abken H; Rieber EP; Temme A
    Prostate; 2007 Jul; 67(10):1121-31. PubMed ID: 17492652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prostate stem cell antigen-derived peptide immunogenic in HLA-A24- prostate cancer patients.
    Matsueda S; Yao A; Ishihara Y; Ogata R; Noguchi M; Itoh K; Harada M
    Prostate; 2004 Aug; 60(3):205-13. PubMed ID: 15176050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody.
    Olafsen T; Gu Z; Sherman MA; Leyton JV; Witkosky ME; Shively JE; Raubitschek AA; Morrison SL; Wu AM; Reiter RE
    J Immunother; 2007; 30(4):396-405. PubMed ID: 17457214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.
    Saffran DC; Raitano AB; Hubert RS; Witte ON; Reiter RE; Jakobovits A
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2658-63. PubMed ID: 11226295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z; Wenlv S
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate.
    Ross S; Spencer SD; Holcomb I; Tan C; Hongo J; Devaux B; Rangell L; Keller GA; Schow P; Steeves RM; Lutz RJ; Frantz G; Hillan K; Peale F; Tobin P; Eberhard D; Rubin MA; Lasky LA; Koeppen H
    Cancer Res; 2002 May; 62(9):2546-53. PubMed ID: 11980648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostate stem cell antigen and related cancers].
    Shu Y; Sun D
    Zhonghua Nan Ke Xue; 2004 May; 10(5):382-4. PubMed ID: 15190837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z; Wenlu S
    Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate stem cell antigen is overexpressed in prostate cancer metastases.
    Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE
    Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling in R-flurbiprofen-treated prostate cancer: R-Flurbiprofen regulates prostate stem cell antigen through activation of AKT kinase.
    Zemskova M; Wechter W; Bashkirova S; Chen CS; Reiter R; Lilly MB
    Biochem Pharmacol; 2006 Nov; 72(10):1257-67. PubMed ID: 16949054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer.
    Joung JY; Yang SO; Jeong IG; Han KS; Seo HK; Chung J; Park WS; Lee KH
    Int J Urol; 2007 Jul; 14(7):635-43. PubMed ID: 17645609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
    Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y
    Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete androgen ablation suppresses prostate stem cell antigen (PSCA) mRNA expression in human prostate carcinoma.
    Zhigang Z; Wenlu S
    Prostate; 2005 Dec; 65(4):299-305. PubMed ID: 16015594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.
    Garcia-Hernandez Mde L; Gray A; Hubby B; Klinger OJ; Kast WM
    Cancer Res; 2008 Feb; 68(3):861-9. PubMed ID: 18245488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
    Petrigliano FA; Virk MS; Liu N; Sugiyama O; Yu D; Lieberman JR
    Prostate; 2009 Sep; 69(13):1422-34. PubMed ID: 19489029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of human prostate cancer cell reactive antibodies using phage display technology.
    Popkov M; Rader C; Barbas CF
    J Immunol Methods; 2004 Aug; 291(1-2):137-51. PubMed ID: 15345312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.